Investor Connect Podcast

Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing.

If you successfully raised your seed round you will find that Series A funding to be a new challenge. 

Series A funding is different from seed funding in several ways.

In seed funding, the entrepreneur must convince the investor that they can sell the product.

In Series A funding, the entrepreneur must convince the investor they can grow the overall business.

In seed funding, product-market fit and traction are the key drivers pointing to success.

In Series A funding, repeatable processes and systems installed are the key drivers.

In seed funding, investments come in bits and pieces and anything helps.

In Series A funding, larger portions must be raised to carry out the plan.

In seed funding, family, friends, angels, and others, are the primary source of funding.

In Series A, venture capital and institutions take the lead in funding.

Make sure you don’t use your seed deck for a Series A funding as you will find the presentation will fall flat.


Thank you for joining us for the Startup Funding Espresso where we help startups and investors connect for funding.

Let’s go startup something today.
___________________________________

For more episodes from Investor Connect, please visit the site at: http://investorconnect.org 

Check out our other podcasts here: https://investorconnect.org/ 
For Investors check out: https://tencapital.group/investor-landing/ 
For Startups check out: https://tencapital.group/company-landing/ 
For eGuides check out: https://tencapital.group/education/ 
For upcoming Events, check out https://tencapital.group/events/ 

For Feedback please contact info@tencapital.group  

Music courtesy of Bensound

Direct download: how_series_a_funding_is_different_from_seed_funding.mp3
Category:general -- posted at: 6:00am CDT

This is Investor Perspectives. I’m the host of Investor Connect, Hall T Martin, where we connect startups and investors for funding.

In our new Investor Perspectives series entitled “How to Solve the Biotech/Life Sciences Problem”, you’ll hear about primary trends and what makes for a successful company in this segment.

As the COVID pandemic passes, we emerge into a new world. The biotech space is now undergoing tremendous change as we shift back to a normal way of life. The process for designing and approving vaccines demonstrated a new protocol. Biotech now moves into a new era. We have investors and startup founders describe the changes coming up.

Our guests are:

Yaniv Sneor, Co-founder, Mid Atlantic Bio Angels 1:17
Carter Williams, CEO and Managing Partner, iSelect Fund 5:58
Maximilian Bade, Founding Partner, Nucleus Capital 15:08
Ron Paliwoda, President, Paliwoda Group 17:09
Orrin Ailloni-Charas, Managing Partner, Global Health Impact Fund 20:09
Eyal Lifschitz, Co-Founder and Managing Partner, Peregrine Ventures 22:57
Mark Groper, Chief Executive Officer, Orion Biotechnology 30:45

We hope you enjoy the show.
_______________________________

For more episodes from Investor Connect, please visit the site at: http://investorconnect.org     

Check out our other podcasts here: https://investorconnect.org/  
For Investors check out: https://tencapital.group/investor-landing/   
For Startups check out: https://tencapital.group/company-landing/   
For eGuides check out: https://tencapital.group/education/  
For upcoming Events, check out https://tencapital.group/events/

For Feedback please contact info@tencapital.group  

Music courtesy of Bensound.


1